Javier Valero-Saez
Alicante, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Meprin-β levels are increased in the brain and the cerebrospinal fluid of Alzheimer's disease patients.
Journal: Alzheimer's research & therapy
Published: April 07, 2026
Cerebrospinal fluid and frontal cortex TMPRSS2 and ACE2 protein levels differ in Down syndrome and Alzheimer's disease.
Journal: Acta neuropathologica communications
Published: October 19, 2025
GluN2A-mediated currents and calcium signal in human iPSC-derived neurons.
Journal: Scientific reports
Published: September 29, 2025
Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations.
Journal: Acta pharmaceutica Sinica. B
Published: August 19, 2025
Selective reduction of ADAM10 in brain and cerebrospinal fluid of Alzheimer's disease patients.
Journal: Alzheimer's research & therapy
Published: August 01, 2025
Development and Validation of an ICP-MS/MS Method for the Multielemental Analysis of Cerebrospinal Fluid, Examination of Alzheimer's Disease Samples.
Journal: Journal of neurochemistry
Published: June 04, 2025
Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological Disorders.
Journal: Journal of neurochemistry
Published: December 22, 2024
Increased Cerebrospinal Fluid Angiotensin-Converting Enzyme 2 Fragments as a Read-Out of Brain Infection in Patients With COVID-19 Encephalopathy.
Journal: The Journal of infectious diseases
Published: October 17, 2024
NMDARs in Alzheimer's Disease: Between Synaptic and Extrasynaptic Membranes.
Journal: International journal of molecular sciences
Published: September 02, 2024
Synaptic and extrasynaptic distribution of NMDA receptors in the cortex of Alzheimer's disease patients.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: March 18, 2024
Last Updated: 09/26/2026